Alternating magnetic field enhances cytotoxicity of Compound C

Cancer Science
Taisuke AkimotoYoshihiro Ishikawa

Abstract

We previously reported the efficacy of anti-cancer therapy with hyperthermia using an alternating magnetic field (AMF) and a magnetic compound. In the course of the study, unexpectedly, we found that an AMF enhances the cytotoxicity of Compound C, an activated protein kinase (AMPK) inhibitor, although this compound is not magnetic. Therefore, we examined the cellular mechanism of AMF-induced cytotoxicity of Compound C in cultured human glioblastoma (GB) cells. An AMF (280 kHz, 250 Arms) for 30 minutes significantly enhanced the cytotoxicity of Compound C and promoted apoptosis towards several human GB cell lines in vitro. The AMF also increased Compound C-induced cell-cycle arrest of GB cells at the G2 phase and, thus, inhibited cell proliferation. The AMF increased Compound C-induced reactive oxygen species production. Furthermore, the AMF decreased ERK phosphorylation in the presence of Compound C and suppressed the protective autophagy induced by this compound. The application of an AMF in cancer chemotherapy may be a simple and promising method, which might reduce the doses of drugs used in future cancer treatment and, therefore, the associated side effects.

References

Jan 7, 2004·Cancer Cell·Aimee L Edinger, Craig B Thompson
Feb 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Reuben J ShawLewis C Cantley
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Apr 18, 2009·Molecular Cancer Therapeutics·Hyeon Ung ParkSean P Collins
Oct 19, 2012·International Journal of Oncology·Hong-Quan DuongInsoo Bae
Jan 1, 2013·Toxicology and Applied Pharmacology·Shi-Wei HuangJeng-Jer Shieh
Jan 15, 2014·Molecular Cancer Therapeutics·Xiaona LiuBiplab Dasgupta
Mar 18, 2015·Scientific Reports·Haruki EguchiYoshihiro Ishikawa
Feb 22, 2017·Scientific Reports·Makoto OhtakeYoshihiro Ishikawa
Aug 7, 2017·Journal of Pharmacological Sciences·Masanari UmemuraYoshihiro Ishikawa
Apr 13, 2018·Oncotarget·Rina NakakajiYoshihiro Ishikawa

❮ Previous
Next ❯

Citations

Oct 31, 2018·Cancer Science·Masanari UmemuraYoshihiro Ishikawa
Jan 28, 2020·ESC Heart Failure·Ryo TanakaYoshihiro Ishikawa
Nov 23, 2019·Cancer Science·Kohei OsawaYoshihiro Ishikawa
Aug 1, 2021·Advanced Drug Delivery Reviews·Shuang WangGuanghui Ma

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
flow

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy Networks

Autophagy is a lysosomal pathway that involves degradation of proteins and functions in normal growth and pathological conditions, through a series of complex networks. The catabolic process involves delivery of proteins and organelles to the lysosome. Here is the latest research on autophagy networks.